The role of inflammatory biomarkers in adolescent major depressive disorder: a systematic review
Abstract
Purpose: Major Depressive Disorder (MDD) in adolescents is an escalating mental health problem with underlying biological pathways. Increasing evi- dence highlights the role of inflammatory response and immune dysregulation in its development and progression. This study aims to explore the role of inflammatory biomarkers in Major Depressive Disorder (MDD) among adolescent populations, elucidating their potential utility for more effective treatment strategies.
Methods: A systematic review was conducted using Ebsco, PubMed, Scopus, Web of Science, and Google Scholar databases. Studies published between 2019 and 2025 that focused on adolescent MDD (aged 10-19 years) and inflammation were included. Study quality was evaluated using the Joanna Briggs Institute (JBI) tool, and narrative analyses were conducted for data synthesis. The PICOS (Population, Intervention, Comparison, Outcome, and Study Design) framework is used to ensure clarity in defining the research question and inclusion criteria. The systematic review was registered in PROSPERO (CRD420251129403).
Results: A total of 29 articles met the inclusion criteria for this study. Across the included studies, elevated levels of pro-inflammatory cytokines, particularly inter- leukin-6 (IL-6) and Tumor Necrosis Factor-Alpha (TNF-α), were consistently associated with MDD in adolescents. Dysregulation of the Hypothalamic- Pituitary-Adrenal (HPA) axis and alterations in anti-inflammatory cytokines such as IL-10 were also observed. These biomarkers were linked to changes in stress hormone regulation.
Conclusion: Inflammatory biomarkers play a significant role in the pathophysiology of MDD among adolescents, offering promising avenues for early detection and personalised intervention. Integrating biomarker assessment into clinical practice may improve diag- nosis and guide targeted treatments.
References
WHO. Adolescent health - SEARO. 2025. Available from: [Website]
Du N, Wang Y, Geng D, Chen H, Chen F, Kuang L, et al. Effects of electroconvulsive therapy on inflammatory markers and depressive symptoms in adolescents with major depressive disorder. Frontiers in Psychiatry. 2024;15:1447839.
Yani DI, Chua JYX, Wong JCM, Pikkarainen M, Goh YSS, Shorey S. Perceptions of mental health challenges and needs of Indonesian adolescents: a descriptive qualitative study. International Journal of Mental Health Nursing. 2025;34(1).
Liu M, Tang J, Xu G, Chen X, Fang K, He F, et al. Investigating the relationship between inflammatory cytokines and adolescent depression: a comparative analysis. Frontiers in Psychiatry. 2025;16:1524015.
WHO. Depressive disorder (depression). Available from: [Website]
Badan Kebijakan Pembangunan Kesehatan. Depresi pada anak muda di Indonesia. 2023. Available from: [Website]
Penninx BWJH, Lamers F, Jansen R, Berk M, Khandaker GM, De Picker L, et al. Immuno-metabolic depression: from concept to implementation. The Lancet Regional Health - Europe. 2025;48:101166
Alfian S, Permata P, Griselda M, Puspitasari I, Abdulah R. Comparing the association between depressive symptoms and cardiovascular disease among the middle-aged and elderly population: a national survey of 9,049 subjects based on the Indonesian family life survey-5. Vascular Health and Risk Management. 2025;21:85–95.
Jadhav KK, Daouk J, Kurkinen K, Kraav SL, Eriksson P, Tolmunen T, et al. Blood cytokines in major depressive disorder in drug-naïve adolescents: A systematic review and meta-analysis. Journal of Affective Disorders. 2025;372:48–55.
Liu W, Zheng H, Wen X, Liu L, Yang Y, Zhong H. Associations of pro-inflammatory factors and IL-10 levels with degree of suicide risk in adolescents with depression. Frontiers in Psychiatry. 2024;15: 1491555.
Jiao W, Lin J, Deng Y, Ji Y, Liang C, Wei S, et al. The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms. Journal of Neuroinflammation. 2025;22(10).
Kouba BR, de Araujo Borba L, Borges de Souza P, Gil-Mohapel J, Rodrigues ALS. Role of inflammatory mechanisms in major depressive disorder: from etiology to potential pharmacological targets. Cells. 2024;13(5):423.
Poletti S, Mazza MG, Benedetti F. Inflammatory mediators in major depression and bipolar disorder. Translational Psychiatry. 2024;14(1): 247.
Poletti S, Melloni E, Aggio V, Colombo C, Valtorta F, Benedetti F, et al. Grey and white matter structure associates with activation of the tryptophan-to-kynurenine pathway in bipolar disorder. Journal of Affective Disorders. 2019; 259:404–412.
Candrarukmi D, Hartanto F, Wibowo T, Nugroho HW, Anam MS, Indraswari BW, et al. Risk factors for depression symptoms in adolescents. Saudi Medical Journal. 2025;46(2):190–198.
Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Systematic Reviews. 2022;18(2):e1230.
The Joanna Briggs Institute. Checklist for systematic reviews and research syntheses. The Joanna Briggs Institute. 2017. Available from: [Website]
Xi YQ, Wang ZQ, Li GJ, Hao ZQ, Nie JH, Li JX, et al. Association of inflammation cytokines with cognitive function in first-episode major depressive disorder. Frontiers in Psychiatry. 2024;15:1473418.
Min X, Wang G, Cui Y, Meng P, Hu X, Liu S, et al. Association between inflammatory cytokines and symptoms of major depressive disorder in adults. Frontiers in Immunology. 2023;14:1110775.
McLachlan C, Shelton R, Li L. Obesity, inflammation, and depression in adolescents. Frontiers in Psychiatry. 2023;14:1221709.
Lee H, Song M, Lee J, Kim JB, Lee MS. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder. Journal of Affective Disorders. 2020;266: 57–62.
Zeng Y, Sun B, Zhang F, Hu Z, Li W, Lan X, et al. The core inflammatory factors in patients with major depressive disorder: a network analysis. Frontiers in Psychiatry. 2023;14:1216583.
Liu F, Yang Y, Fan XW, Zhang N, Wang S, Shi YJ, et al. Impacts of inflammatory cytokines on depression: a cohort study. BMC Psychiatry. 2024;24:195.
Elgellaie A, Thomas SJ, Kaelle J, Bartschi J, Larkin T. Pro-inflammatory cytokines IL-1α, IL-6 and TNF-α in major depressive disorder: Sex-specific associations with psychological symptoms. The European Journal of Neuroscience. 2023;57(11):1913–28.
Zajkowska Z, Nikkheslat N, Manfro PF, Souza L, Rohrsetzer F, Viduani A, et al. Sex-specific inflammatory markers of risk and presence of depression in adolescents. Journal of Affective Disorders. 2023;342:69–75.
Tsang RSM, Stow D, Kwong ASF, Donnelly NA, Fraser H, Barroso I, et al. Immunometabolic blood biomarkers of developmental trajectories of depressive symptoms: findings from the ALSPAC birth cohort. Molecular Psychiatry. 2025.
Ji Y, Wang J, Chen H, Li J, Chen M. Association between hs-CRP and depressive symptoms: a cross-sectional study. Frontiers in Psychiatry. 2024; 15:1339208.
Saadat SH, Javanbakht M, Shahyad S. Brain-derived neurotrophic factor and C-reactive protein (CRP) biomarkers in suicide attempter and non-attempter major depression disorder (MDD) patients. Annals of General Psychiatry. 2024;23(1):27.
Batail JM, Corouge I, Blanchard T, Roy JC, Robert G, Drapier D. Inflammatory and MRI perfusion biomarkers in predicting persistence of depression: a 6-month longitudinal study. Translational Psychiatry. 2025;15:370.
De Azeredo LA, Viola TW, Rothmann LM, Trentin R, Arteche AX, Kristensen CH, et al. Hair cortisol levels and mental health problems in children and adolescents exposed to victimization. Stress. 2020; 23(5):546–55.
Bendezú JJ, Calhoun CD, Vinograd M, Patterson MW, Rudolph KD, Giletta M, et al. Exploring joint HPA–inflammatory stress response profiles in adolescent girls: Implications for developmental models of neuroendocrine dysregulation. Developmental Psychobiology. 2022;64(3):e22247.
Hadjicharalambous M, Chalari E, Zaras N. Influence of puberty stage in immune-inflammatory parameters in well-trained adolescent soccer-players, following 8-weeks of pre-seasonal preparation training. Exploration of Immunology. 2024;4:822–36.
Chronister BN, Gonzalez E, Lopez-Paredes D, Suarez-Torres J, Gahagan S, Martinez D, et al. Testosterone, estradiol, DHEA and cortisol in relation to anxiety and depression scores in adolescents. Journal of Affective Disorders. 2021; 294:838–46.
Fung MH, Taylor BK, Embury CM, Spooner RK, Johnson HJ, Willett MP, et al. Cortisol changes in healthy children and adolescents during the COVID-19 pandemic. Stress. 2022;25(1):323–30.
Brosch K, Stein F, Meller T, Schmitt S, Yuksel D, Ringwald KG, et al. DLPFC volume is a neural correlate of resilience in healthy high-risk individuals with both childhood maltreatment and familial risk for depression. Psychological Medicine. 2022;52(16):1-7.
Zonca V, Marizzoni M, Saleri S, Zajkowska Z, Manfro PH, Souza L, et al. Inflammation and immune system pathways as biological signatures of adolescent depression—the IDEA-RiSCo study. Translational Psychiatry. 2024;14(1):230.
Gabbay V, Ely BA, Vileisis JN, Petrovic Z, Cicvaric A, Asnis GM, et al. Immune and neural response to acute social stress in adolescent humans and rodents. Translational Psychiatry. 2024.
Wu Y, Lu Y, Kong L, Xie Y, Liu W, Yang A, et al. Gender differences in plasma S100B levels of patients with major depressive disorder. BMC Psychiatry. 2024;24(1):387.
Shen Z, Cui L, Mou S, Ren L, Yuan Y, Shen X, et al. Combining S100B and cytokines as neuro-inflammatory biomarkers for diagnosing generalized anxiety disorder: a proof-of-concept study based on machine learning. Frontiers in Psychiatry. 2022;13:881241.
Dawood S, Bano S, Badawy AAB. Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases. Bioscience Reports. 2022;42(5):BSR20220426.
Kaszás A, Kelemen O, Kéri S. Magnetic resonance imaging signatures of neuroinflammation in major depressive disorder with religious and spiritual problems. Scientific Reports. 2025;15:5407.
Zwolińska W, Dmitrzak-Węglar M, Słopień A. Biomarkers in child and adolescent depression. Child Psychiatry & Human Development. 2023; 54:266–81.
Ohrnberger J, Fichera E, Sutton M. The relationship between physical and mental health: A mediation analysis. Social Science & Medicine. 2017;195:42–9.
Knezevic E, Nenic K, Milanovic V, Knezevic NN. The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders. Cells. 2023; 12(23):2726.
Jones DR, Graham-Engeland JE. Positive affect and peripheral inflammatory markers among adults: A narrative review. Psychoneuroendocrinology. 2021; 123:104892.
Correia AS, Cardoso A, Vale N. BDNF unveiled: exploring its role in major depression disorder serotonergic imbalance and associated stress conditions. Pharmaceutics. 2023;15(8):2081.
Zwolińska W, Bilska K, Tarhonska K, Reszka E, Skibińska M, Pytlińska N, et al. Biomarkers of depression among adolescent girls: BDNF and epigenetics. International Journal of Molecular Sciences. 2024;25(6):3281.
Armstrong-Carter E, Telzer EH. Adolescents take more risks on days they have high diurnal cortisol or emotional distress. Comprehensive Psychoneuroendocrinology. 2022;9:100106.
Joyce MKP, Uchendu S, Arnsten AFT. Stress and inflammation target dorsolateral prefrontal cortex function: neural mechanisms underlying weakened cognitive control. Biological Psychiatry. 2025;97(4): 359–71.
Müller L, Di Benedetto S, Müller V. From homeostasis to neuroinflammation: insights into cellular and molecular interactions and network dynamics. Cells. 2025;14(1):54.
Fung MH, Rahman RL, Taylor BK, Frenzel MR, Eastman JA, Wang YP, et al. The impact of pubertal DHEA on the development of visuospatial oscillatory dynamics. Human Brain Mapping. 2022; 43(17):5154-66.
Kim KY, Shin KY, Chang KA. Potential inflammatory biomarkers for major depressive disorder related to suicidal behaviors: a systematic review. International Journal of Molecular Sciences. 2023; 24(18):13907.
Ruiz NAL, Del Ángel DS, Brizuela NO, Peraza AV, Olguín HJ, Soto MP, et al. Inflammatory process and immune system in major depressive disorder. International Journal of Neuropsychopharma- cology. 2022;25(1):46–53.
Islam MR, Sohan M, Daria S, Masud A Al, Ahmed MU, Roy A, et al. Evaluation of inflammatory cytokines in drug-naïve major depressive disorder: A systematic review and meta-analysis. International Journal of Immunopathology and Pharmacology. 2023;37:3946320231198828.
Orsolini L, Pompili S, Valenta ST, Salvi V, Volpe U. C-reactive protein as a biomarker for major depressive disorder?. International Journal of Molecular Sciences. 2022;23(3):1616.
Felger JC, Haroon E, Patel TA, Goldsmith DR, Wommack EC, Woolwine BJ, et al. What does plasma CRP tell us about peripheral and central inflammation in depression?. Molecular Psychiatry. 2020;25(6):1301–11.
Halaris A, Prochaska D, Stefanski A, Filip M. C-reactive protein in major depressive disorder: promise and challenge. Journal of Affective Disorders Reports. 2022;10:100427.
Mudra Rakshasa-Loots A, Vera JH, Laughton B. Neuroinflammation and mental health outcomes in adolescents living with HIV. Current Opinion in HIV and AIDS. 2024;19(6):355–60.
Raison CL. Microglial activation and response to anti-inflammatory treatment in major depressive disorder: another piece in the inflammation–mood disorders puzzle. Biological Psychiatry. 2020;88 (8):594–6.
Liu F, Guo D, Gao T, Diao M, Han Y. Microglia in the pathogenesis of depression, insomnia and their comorbidity. Brain Behavior and Immunity Integrative. 2023;4:100030.
Trasolini M, Serra G, Iannoni ME, Andracchio E, Apicella M, Maglio G, et al. Depression severity and verbal comprehension in children and adolescents with a major depressive episode. Frontiers in Psychiatry. 2024;15:1395391.
Moon DU, Kim H, Jung JH, Han K, Jeon HJ. Suicide risk and living alone with depression or anxiety. JAMA Network Open. 2025;8(3):e251227.
Lee B, Shin E, Song I, Chang B. Depression in adolescence and brain-derived neurotrophic factor. Frontiers in Molecular Neuroscience. 2022;15: 947192.
Xia X, Li K, Zou W, Wang L. The central role of microglia in major depressive disorder and its potential as a therapeutic target. Frontiers in Behavioral Neuroscience. 2025;19:1598178.
Bourgognon JM, Cavanagh J. The role of cytokines in modulating learning and memory and brain plasticity. Brain and Neuroscience Advances. 2020;4: 239821282097980.
Porter GA, O’Connor JC. Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?. World Journal of Psychiatry. 2022;12(1):77–97.
Goldsmith DR, Bekhbat M, Mehta ND, Felger JC. Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology. Biological Psychiatry. 2023;93(5):405–18.
Pappas I, Yu T, Liu O, Srinivasan N. Adolescent brain development under stress and trauma: evidence-based treatments. Berkeley Pharma Tech Journal of Medicine. 2025;5(1):36-72.
Yin Y, Ju T, Zeng D, Duan F, Zhu Y, Liu J, et al. “Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression. Pharmacological Research. 2024;207:107322.
Hassamal S. Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Frontiers in Psychiatry. 2023;14:1130989.
Pastis I, Santos MG, Paruchuri A. Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis. Frontiers in Behavioral Neuroscience. 2024;17:1282242.
Copyright (c) 2026 Cityta Putri Kwarta, Mike Permata Sari, Suharti, Tonny Sundjaya, Prihatini Dini Novitasari, Kumar Taufik
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
